Pill can slash risk of cancer for up to 35 years

  • The study of 46,000 women – the longest ever conducted – found the protective benefits last for 35 years after they stop taking the oral contraceptive pill
  • British women in study took drug for three years on average when in 20s and 30s
  • But protection from cancer lasted until their 50s, 60s, and 70s, research found 
  • Some 3.5million women in Britain take the Pill, which is by far the most popular method of contraception 

Ben Spencer Medical Correspondent For The Daily Mail

97

View
comments

Women who take the Pill while young are at lower risk of ovarian, womb and bowel cancer more than three decades later, landmark research has found.

The study of 46,000 women – the longest ever conducted – concluded that the protective benefits last for 35 years after they stop taking the oral contraceptive pill.

The British women in the study took the drug for just three and a half years on average when they were in their 20s and 30s. 

The study of 46,000 women – the longest ever conducted – found the protective benefits last for 35 years after they stop taking the oral contraceptive pill
The study of 46,000 women – the longest ever conducted – found the protective benefits last for 35 years after they stop taking the oral contraceptive pill

The study of 46,000 women – the longest ever conducted – found the protective benefits last for 35 years after they stop taking the oral contraceptive pill

But the protection from cancer lasted until their 50s, 60s, and 70s – the age when they would usually be at greatest risk.

And they were at no greater risk of other forms of cancer – a finding that will reassure those who take the Pill.

The researchers, from the University of Aberdeen, calculated that women who had taken the Pill were a third less likely than women who had never taken the drug to ever develop cancer of the ovaries or the endometrial – the lining of the womb.

And they were a fifth less likely to develop bowel cancer.

Some 3.5million women in Britain take the Pill, which is by far the most popular method of contraception.

Experts last night said the study, published in the American Journal of Obstetrics and Gynaecology, would ‘significantly alter’ the public’s view of the risks and benefits of the drug.

Some 3.5million women in Britain take the Pill, which is by far the most popular method of contraception
Some 3.5million women in Britain take the Pill, which is by far the most popular method of contraception

Some 3.5million women in Britain take the Pill, which is by far the most popular method of contraception

Women have long been told if they take the Pill they may be at higher risk of breast cancer or cervical cancer. But the study showed these risks do not last long, disappearing completely five years after they stopped taking the Pill. By the time women have gone through the menopause – the time when most cancers occur – those who have taken the Pill in the past are at no additional risk of any cancer, the researchers found.

The Aberdeen team wrote: ‘These results provide stronger evidence that most women do not expose themselves to long-term cancer harm if they choose to use oral contraception; indeed many are likely to be protected.’

They found that for every 100,000 women who took the Pill, 22 would develop ovarian cancer at some point in their life, compared to 33 who never took the drug.

Some 48 users would develop bowel cancer, compared to 59 non-users, and 19 women who took the Pill would develop endometrial cancer, compared to 30 who did not.

The Pill works by artificially raising levels of the sex hormones oestrogen and progesterone, which stop the ovaries from ovulating.

Additional oestrogen increases the risk of breast cancer and cervical cancer – the focus of research fears in the past. But scientists think this risk is offset by the reduction in ovulation – which cuts the risk of ovarian and endometrial cancer.

They are not yet sure why bowel cancer is affected.

The study involved 23,000 women from across the UK who used the combined oral contraceptive pill, and 23,000 who did not. They were tracked until 2012.

Professor Helen Stokes-Lampard, of the Royal College of GPs, said: ‘Millions of women who use the combined oral contraceptive pill should be reassured by this comprehensive research that they are not at increased risk of cancer as a result – and that taking the Pill might actually decrease their risk of certain cancers.’

 

Comments 98

Share what you think

The comments below have not been moderated.

The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.

Close

Your comment will be posted to MailOnline as usual.

Your comment will be credited to your MailOnline persona.

Close

Your comment will be posted to MailOnline as usual

We will automatically post your comment and a link to the news story to your Facebook timeline at the same time it is posted on MailOnline. To do this we will link your MailOnline account with your Facebook account. We’ll ask you to confirm this for your first post to Facebook.

The post will be credited to your MailOnline username. You can choose on each post whether you would like it to be posted to Facebook. Your details from Facebook will be used to provide you with tailored content, marketing and ads in line with our Privacy Policy.